Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "MitoGlobalPlayer invitation"

From Bioblast
Line 1: Line 1:
  '''Bioblast alert''' (2013-02-07)
  '''Bioblast alert''' (2013-02-10)


<big>'''Functional Mitochondrial Diagnosis'''</big>  
<big>'''Functional Mitochondrial Diagnosis'''</big>  
Line 7: Line 7:


    
    
We would like to integrate information on '''approaches to functional diagnosis of mitochondrial diseases'''. Specifically, we would be glad if you can quickly provide us with a [''Yes/No''] to the following questions. Section 3 is general, for all mitochondrial labs independent of diagnostic involvement.
We would like to integrate information on '''approaches to functional diagnosis of mitochondrial diseases'''. We would be glad if you take a couple of minutes for answering questions in Section 1 on diagnostic approaches, and the general questions in Section 2.


 
'''1.'''  Is your lab involved in '''diagnostic evaluation of mitochondrial defects''' in patients using any of the followin models: [''Yes / No'']
'''1.'''  Is your lab involved in '''diagnostic evaluation of mitochondrial defects''' in patients? [''Yes / No'']
:: a) [''Y/N'']: Isolated mitochondria 
 
:: b) [''Y/N'']: Specific enzymes
: If ''Yes'':
:: c) [''Y/N'']: Tissue homogenate
'''2.  Which models''' do you apply for functional mitochondrial diagnosis:
:: d) [''Y/N'']: Permeabilized tissue, muscle fibres
:: a) Isolated mitochondria  [''Y/N'']
:: e) [''Y/N'']: Permeabilized cells
:: b) Specific enzymes [''Y/N'']
:: f) [''Y/N'']: Intact cultured cells (fibroblasts, ..)
:: c) Tissue homogenate [''Y/N'']
:: g) [''Y/N'']: Blood cells (platelets, monocytes, ..)
:: d) Permeabilized tissue, muscle fibres [''Y/N'']
:: h) [''Y/N'']: In vivo (ergometry, MRI, ..)
:: e) Permeabilized cells [''Y/N'']
:: f) Intact cultured cells (fibroblasts, ..) [''Y/N'']
:: g) Blood cells (platelets, monocytes, ..) [''Y/N'']
:: h) In vivo (ergometry, MRI, ..) [''Y/N'']
:: i) If you can add any further information, this would be highly appreciated: e.g. tissue, cell types; specific mt-diseases; other ...
:: i) If you can add any further information, this would be highly appreciated: e.g. tissue, cell types; specific mt-diseases; other ...


    
    
'''3.'''  Do you want to be listed as a [[MitoGlobal_Centres|Mitochondrial Global Network Centre]] [Yes / No]
'''2.'''  Do you want to be listed in the [[Mitochondrial Global Network]] as a [[MitoGlobal_Centres|MitoGlobalPlayer]]' with the following fields of research: [''Yes / No'']
: If ''Yes'' - field of research of your centre
:: a) [''Y/N'']: Basic
:: a) Basic [Y / N]
:: b) [''Y/N'']: Clinical
:: b) Clinical [Y / N]
:: c) [''Y/N'']: Veterinary
:: c) Veterinary [Y / N]
:: d) [''Y/N'']: Diagnostic
:: d) Diagnostic [Y / N]  
:: e) [''Y/N'']: Pharmacological
:: e) Pharmacological [Y / N]
:: f) Other: ...
:: f) Other ...


    
    
If your centre is listed already under [[MitoGlobal_Centres]], please check if the contact details and all information are correct. Based on your valuable feedback, specific diagnostic links may be established, evaluating the possibility of joint project proposals, organization of workshops, or other forms of collaboration.  
If you are listed already as in the [[MitoGlobal_Centres|Mitochondrial Global Network]], please check if the contact details and all information are correct. Based on your valuable feedback, specific diagnostic links may be established, evaluating the possibility of joint project proposals, organization of workshops, or other forms of collaboration.  


    
    

Revision as of 22:56, 10 February 2013

Bioblast alert (2013-02-10)

Functional Mitochondrial Diagnosis


Dear colleague,


We would like to integrate information on approaches to functional diagnosis of mitochondrial diseases. We would be glad if you take a couple of minutes for answering questions in Section 1 on diagnostic approaches, and the general questions in Section 2.

1. Is your lab involved in diagnostic evaluation of mitochondrial defects in patients using any of the followin models: [Yes / No]

a) [Y/N]: Isolated mitochondria
b) [Y/N]: Specific enzymes
c) [Y/N]: Tissue homogenate
d) [Y/N]: Permeabilized tissue, muscle fibres
e) [Y/N]: Permeabilized cells
f) [Y/N]: Intact cultured cells (fibroblasts, ..)
g) [Y/N]: Blood cells (platelets, monocytes, ..)
h) [Y/N]: In vivo (ergometry, MRI, ..)
i) If you can add any further information, this would be highly appreciated: e.g. tissue, cell types; specific mt-diseases; other ...


2. Do you want to be listed in the Mitochondrial Global Network as a MitoGlobalPlayer' with the following fields of research: [Yes / No]

a) [Y/N]: Basic
b) [Y/N]: Clinical
c) [Y/N]: Veterinary
d) [Y/N]: Diagnostic
e) [Y/N]: Pharmacological
f) Other: ...


If you are listed already as in the Mitochondrial Global Network, please check if the contact details and all information are correct. Based on your valuable feedback, specific diagnostic links may be established, evaluating the possibility of joint project proposals, organization of workshops, or other forms of collaboration.


By return Email, you will receive a link to your MitoGlobal page on the Bioblast wiki.


This is a project in the spirit of Gentle Science. With many thanks and best wishes,


Erich Gnaiger, A.Univ.-Prof., PhD

D. Swarovski Research Laboratory

Medical University of Innsbruck

MitoCom Tyrol


Erich Gnaiger, PhD, CEO

OROBOROS INSTRUMENTS Corp.

high-resolution respirometry

Schöpfstrasse 18, A-6020 Innsbruck, Austria

T +43 512 566796; F +43 512 566796 20

Email: [email protected]

http://www.oroboros.at